ArticleJSES reviews, reports, and techniques2023
Healthcare costs of failed rotator cuff repairs.
Article in JSES reviews, reports, and techniques, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.
- Structural Augmentation in Rotator Cuff Repair Decreases the Risk of Retear: A Systematic Review and Meta-analysis.The American journal of sports medicine · 2026Pooled it
- Effect of Subacromial Bursa Augmentation on Self-Reported and Magnetic Resonance Imaging Outcomes in Arthroscopic Rotator Cuff Repair: A Prospective, Blinded Randomized Clinical Trial.The American journal of sports medicine · 2026Trial
- The Tendon-to-Bone Seam: A Transtendinous Approach to Rotator Cuff Repair.Arthroscopy techniques · 2026Article
- Augmentation for rotator cuff repair - clinical use patterns and limited patient access: the American Shoulder and Elbow Surgeons bio-advocacy work group survey.JSES reviews, reports, and techniques · 2026Article
- Rotator cuff disease, repair and augmentation.Bulletin of the Hospital for Joint Disease (2013) · 2026Review
- Automated 3D segmentation of rotator cuff muscle and fat from longitudinal CT for shoulder arthroplasty evaluation.Skeletal radiology · 2026Article
- Use of Patch Augmentation in Rotator Cuff Repair: A Systematic Review Protocol.Revista brasileira de ortopedia · 2025Article
- [Use of Patch Augmentation in Rotator Cuff Repair: A Systematic Review Protocol].Revista brasileira de ortopedia · 2025Article
- Rotator Cuff Repair With a Sutureless PEEK Implant.Arthroscopy techniques · 2025Article
- Preoperative pupillary metrics as predictors of postoperative acute and chronic pain following thoracoscopic surgery: a prospective study.American journal of translational research · 2025Article
- Overexpression of PRDM16 improves muscle function after rotator cuff tears.Journal of shoulder and elbow surgery · 2024Article
- Doctor shopping trend of patients before undergoing rotator cuff repair in Korea: a multicenter study.Clinics in shoulder and elbow · 2024Article
- Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study.Biomedicines · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The goal of this study was to estimate the short-term (∼2 years) healthcare costs of failed primary arthroscopic rotator cuff repair (RCR) in the United States. Methods: A review of current literature was performed to estimate the number of RCR performed in the United States in the year 2022 and the rate of progression of these patients to lose repair continuity, reach clinical failure, and progress to nonoperative intervention and revision procedures. A review of the current literature was performed to estimate the costs incurred by these failures over the ensuing 2-year postoperative time period. Results: The direct and indirect healthcare costs of structural and clinical failure of primary RCR performed in 2022 are estimated to reach $438,892,670 in the short-term postoperative period. The majority of the costs come from the estimated $229,390,898 in nonoperative management that these patients undergo after they reach clinical failure. Conclusion: The short-term healthcare costs of failed arthroscopic RCR performed in the United States in 2022 are predicted to be $438,892,670. Although RCR improves quality of life, pain, function, and is cost-effective, there remains great potential for reducing the economic burden of failed RCR repairs on the US society. Investments into research aimed to improve RCR healing rates are warranted. Clinical Relevance: Although RCR improves quality of life, pain, function, and is cost-effective, this study provides evidence that there remains great potential for reducing the economic burden of failed RCR repairs on the US society. Investments into research aimed to improve RCR healing rates are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.